Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Wix Unveils Wixel: Revolutionizing Visual Design for All Creators
- C3is Inc. Unveils First Quarter Performance and Future Outlook
- Vaso Corporation Reports Record Revenue and Financial Updates
- Rogers Xfinity TV Expands International Channel Offering
- Exciting New Fresca Salads & Wraps Unveiled at El Pollo Loco
- Enhancing Telehealth: Treatment.com and Rocket Doctor's Vision
- Intuitive's Leadership Change: Dave Rosa Steps Up as CEO
- Insights from the 2025 Annual General Meeting of Ensurge Micropower
- Revolutionizing Animation: Cartwheel's Innovative 3D Platform
- Celebrating Excellence: KellyOCG's Top Suppliers for 2024
- Myles Turner Partners with MyFitnessPal for Nutrition Excellence
- Understanding the Challenges and Solutions for Neurodiversity
- Introducing the Revolutionary Arc Coast: A New Era in Boating
- Swimply Expects Surge in Pool Rentals This Summer Season
- Diane Brassard Joins Roots to Propel AI Growth in Insurance
- Legal Details on Costa Sunglasses Class Action for Consumers
- Class Action Alert for Twitter Stockholders: Important Updates
- Suntory Global Spirits Unveils New Vodka Seltzer Flavors
- Uncover Unique Experiences with Exclusive Hotel Offer
- Abbott's Revolutionary Glucose Technology Reduces Hospital Visits
- Culinary Institute Partners with Thimus for Food Research
- Unleashing Efficiency: Supermicro’s DCBBS for AI Data Centers
- Alley Cat Allies Celebrates 5000 Cats Helped with TNR Project
- Tyla to Shine as Host at Nickelodeon Kids' Choice Awards 2025
- Transforming Connections: RM11's Unique Video Call Offering
- Spectral Capital Engages in $15 Million Boost for Loyalty Tech
- Transforming Fertility Care: HRC Fertility Leads Change
- gutzy Organic® Unveils Exciting New Protein Smoothie Pouches
- Nokia and Celesta Capital Unveil Astranu for Healthcare Imaging
- AAKOMA Project Launches Groundbreaking Mental Health Study
- Vocodia Holdings Expands Forward with $3 Million Funding Strategy
- Five Star Franchising Welcomes Jacob Hanika as New VP
- Tiny Home Innovations Proposed to Solve Housing Dilemma
- Exceptional Antique Toy Collection Auction by Morphy's
- BOE's Green Eco-Forum: Shaping A Sustainable Future Together
- Synder's New Integration with NetSuite Enhances Automation
- Autonomix Medical Secures Major Patent for Catheter Technology
- Revolutionizing Life Sciences with Domain-Trained AI Solutions
- Vivos Inc. Expands Cancer Treatment Options with IsoPet Therapy
- Captivating Love Story 'A Season For Love' Debuts Soon
- Automox Welcomes New CEO Justin Talerico for Future Growth and Innovation
- Celebrating Empowerment: Patricia Nash at QVC's Q50 Ambassadors
- Exploring the Growth of the TRISO Fuel Market Up to 2033
- Jim Buck's Remarkable Journey to EY Entrepreneur Finalist
- North America's Drone Market Set to Soar to $31 Billion
- Sunrise Senior Living Expands Reach with Griffin Living Alliance
- Exploring Growth Trends in the Laser Hair Removal Industry
- Yello Introduces Innovative Hello App for Enhanced Campus Engagement
- Meta Earth Unveils Innovative Blockchain for a New Economy
- Solestial Secures $17 Million in Series A Financing for Growth